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Abstract
Objectives: Cell-based therapy has been reported to repair or restore damaged salivary gland (SG) tissue after irradiation.
This study was aimed at determining whether systemic administration of human adipose-derived mesenchymal stem cells
(hAdMSCs) can ameliorate radiation-induced SG damage.
Methods: hAdMSCs (16106) were administered through a tail vein of C3H mice immediately after local irradiation, and then
this infusion was repeated once a week for 3 consecutive weeks. At 12 weeks after irradiation, functional evaluations were
conducted by measuring salivary flow rates (SFRs) and salivation lag times, and histopathologic and immunofluorescence
histochemistry studies were performed to assay microstructural changes, apoptosis, and proliferation indices. The
engraftment and in vivo differentiation of infused hAdMSCs were also investigated, and the transdifferentiation of hAdMSCs
into amylase-producing SG epithelial cells (SGCs) was observed in vitro using a co-culture system.
Results: The systemic administration of hAdMSCs exhibited improved SFRs at 12 weeks after irradiation. hAdMSC-
transplanted SGs showed fewer damaged and atrophied acinar cells and higher mucin and amylase production levels than
untreated irradiated SGs. Immunofluorescence TUNEL assays revealed fewer apoptotic cells in the hAdMSC group than in
the untreated group. Infused hAdMSCs were detected in transplanted SGs at 4 weeks after irradiation and some cells were
found to have differentiated into SGCs. In vitro, a low number of co-cultured hAdMSCs (13%–18%) were observed to
transdifferentiate into SGCs.
Conclusion: The findings of this study indicate that hAdMSCs have the potential to protect against irradiation-induced cell
loss and to transdifferentiate into SGCs, and suggest that hAdMSC administration should be viewed as a candidate therapy
for the treatment of radiation-induced SG damage.
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Introduction
Salivary hypofunction with its subjective symptom of dry mouth
(xerostomia) is the most significant long-term complication of
radiotherapy for the treatment of head and neck cancers. Each
year, 500,000 new cases of head and neck cancer develop
worldwide and the majority of advanced cases require radiother-
apy with or without chemotherapy as a primary or adjuvant
treatment following surgery. A systematic review by Jensen et al.
revealed that the prevalence of xerostomia ranges from 74 to 85%
after all radiation therapies for head and neck cancer, and that
salivary secretion and xerostomia showed incomplete improve-
ments, even after parotid-sparing intensity-modulated radiation
therapy. [1].
Saliva is required for digestion, lubrication, oral homeostasis,
and for protection against a variety of noxious materials and
microorganisms, and salivary hypofunction resulting from radia-
tion damage to the salivary glands (SG) can cause various life-
disrupting side effects, such as, swallowing difficulties, taste loss,
oral candidiasis, and dental caries. [2] Furthermore, hyposaliva-
tion may be an irreversible life-long condition and significantly
affect quality of life. Nevertheless, no satisfactory therapy has been
devised to treat salivary hypofunction, and current treatment
strategies are confined to the minimization of SG radiation
damage by parotid-sparing radiation delivery or conservative care
based on the use of salivary substitutes and sialogogues. [3].
Interest in therapeutic strategies designed to repair and/or
restore damaged SGs is increasing, and in the context of tissue
engineering and regenerative medicine, these strategies include the
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re-implantation of autologous SG cells, [4] the implantation of
engineered artificial SGs, [5] stem cell therapy, [6,7] and gene
therapy. [8] Bone-marrow-derived cells (BMCs) were recently
proposed as potential candidates for the treatment of salivary
hypofunction.[9–12] Adipose tissue-derived mesenchymal stem
cells (AdMSCs) are another potent source of adult stem cells, and
can be readily aspirated using a minimally invasive procedure and
are relatively unaffected by donor age. In addition, adipose tissues
contain higher densities of MSCs than bone marrow. [13] For
these reasons, AdMSC based treatments for a variety of diseases
have been investigated for use in the tissue engineering and
regenerative medicine fields.
Stem cells have an inherent ability to mobilize to injured tissues,
for example, adult BMCs intravenously delivered to rats after
myocardial infarction homed to infarcted regions and improved
ventricular function, whereas stem cells delivered to noninfarcted
rats localized to bone marrow. [14] Lombaert et al. found that
BMCs pretreated with a mobilizing agent, mobilized to irradiated
glands, and ameliorated acinar cell loss and vascular damage.
[10,11] If safety concerns regarding the intravenous infusion of
stem cells are met, they would provide a straightforward and
minimally invasive means of delivery.
We undertook the present study to determine whether the
systemic administration of human adipose-derived mesenchymal
stem cells (hAdMSCs) could mobilize to damaged SGs and
ameliorate radiation-induced SG damage. In addition, we studied
whether the systemic transplantation of hAdMSCs into the
irradiated SGs could provide protection against radiation-induced
apoptosis, increase SG regeneration, and transdifferentiate into
salivary gland epithelial cells (SGCs) of endodermal lineage.
Materials and Methods
Ethics Statement
This study was approved by the Animal Ethics Committee of
Inha University Hospital (Permit Number: 110829-110). Animals
were cared for according to established institutional guidelines,
and all efforts were made to minimize suffering. Surgeries were
performed under anesthesia after xylazine (10 mg/kg) premedi-
cation and an intraperitoneal injection of ketamine (110 mg/kg),
and all efforts were made to minimize suffering.
Preparation of hAdMSCs
hAdMSCs were prepared from surplus banked stem cells under
good manufacturing practice (GMP) conditions (RNL Bio, Seoul)
and used as ‘anonymized’ materials. IRB approval for use of the
cells was not required for the research. [15] In brief, human
abdominal subcutaneous fat tissues were obtained by simple
liposuction with informed consent from donors. Aspirated fat
tissues were separated from fluids by centrifugation and digested
with RNase (RNL Bio, Seoul) for 60 min at 37uC. The digested
tissues were filtered through a 100 mm nylon sieve to remove
cellular debris, and the pellets obtained by centrifugation were
resuspended in RCME cell attachment medium (RNL BIO)
containing 10% fetal bovine serum (FBS; Invitrogen, Carlsbad,
CA) and cultured overnight at 37uC. After 24 h, the cell medium
was changed to RKCM cell growth medium (RNL Bio) containing
5% FBS. When the cells reached 80–90% confluency, they were
subcultured and expanded in RKCM. They were further
characterized for MSC identification and cells in their third
passage were used for experiments.
Flow cytometry. For cell surface phenotyping, undifferenti-
ated hASC were stained with phycoerythrin (PE)- or fluorescein-
isothiocyanate (FITC)-conjugated antibodies against human anti-
gens CD29 (PE-555443), CD31 (FITC-555445), CD34 (PE-
555822), CD44 (FITC-555478), CD45 (FITC-555482), CD73
(PE-550257), CD90 (PE-555596), CD105 (PE-560839), HLA-
ABC (FITC-555552) and HLA-DR (FITC-555811) (all from BD
Pharmingen, San Diego, CA) and analyzed by fluorescent-
activated cell sorting using FACSCalibur and CellQuest software
(BD Biosciences, San Jose, CA).
In vitro differentiation. The abilities of hAdMSCs to
differentiate into the osteogenic, adipogenic, and chondrogenic
lineage were investigated. Osteogenic or adipogenic differentiation
was induced by culturing cells for 3 weeks in osteogenic or
adipogenic medium (Miltenyi Biotec, Gladbach, Germany). Media
were changed three times per week. The osteogenic differentiation
of hAdMSCs was assessed by evaluating morphological changes
and calcified extracellular matrix deposition as demonstrated by
positive Alizarin red staining. Adipogenesis was measured by
staining lipid droplets with Oil Red O. Cells cultured in standard
cell culture medium were used as undifferentiated controls.
Chondrogenic differentiation was induced over 14 days in
pellets maintained in polypropylene tubes in 50% fresh chondro-
genic medium (Lonza, Walkersville, MD), which was replaced
every third day. Chondrogenesis was evaluated by histological
toluidine blue staining of pellet sections at Green Cross Co.
(Yongin, Korea).
Animal Model
Eight to nine-week-old female C3H mice weighing 18 , 22 g
were purchased from the Research Model Producing Center
(Orient Bio, Gyeonggi-Do, Korea). Animals were maintained
under conventional clean conditions, and provided with standard
laboratory chow and sterilized water ad libitum.
To cause irradiation-induced salivary dysfunction, animals were
firmly fixed in a plastic mold and irradiated with a 4 MV X-ray
from a linear accelerator (Mevatron MD, Siemens Medical
Laboratories Inc., Germany) using a single dose of 15 Gy at a
focus-to-skin distance of 100 cm. Animals were locally irradiated
in the head and neck region, including the salivary gland, with
bodies shielded from the radiation field. The dosage required to
induce hyposalivation without compromising general health was
calculated as described previously. [16].
Transplantation
Experimental animals were randomly divided into 3 groups of
20 mice, namely, a non-irradiated group (the normal control
group), an irradiated/untreated group (the irradiated group), and
a group that received hAdMSCs after irradiation (the hAdMSC
group). Mice in the hAdMSC group received 16106 hAdMSCs
through a tail vein immediately after irradiation, and this infusion
was repeated weekly for 3 consecutive weeks (Fig. S1).
Morphological and Functional Evaluations
Gland and body weights. Body weights were measured at
12 weeks after irradiation and followed by saliva collection and
humane euthanasia. Submandibular glands were harvested and
surrounding fat and connective tissues were removed. The weights
of both submandibular glands were measured before fixation in
10% neutral formalin buffer and embedding in paraffin.
Salivary flow rates and lag times. Salivary secretory
function was determined by measuring salivary flow rates (SFRs)
and lag times at 12 weeks after irradiation. Saliva was collected
from the floor of the mouth using a micropipette for 5 min after
stimulation with an intraperitoneal injection with pilocarpine
(2 mg/kg). Collected saliva was placed in pre-weighed 1.5 ml
microcentrifuge tubes and SFR (mL/min) was calculated by
Regeneration of Radiation-Induced Salivary Damage
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dividing the weight (mg) of all saliva collected by the collection
time (min) (saliva was assumed to have a specific gravity of 1 mg/
mL). Salivary lag time was defined as time from stimulation to the
beginning of saliva secretion.
Histological and Immunohistochemical Evaluations of
Changes in the Structure and Functionalities of Acinar
Cells
After deparaffinization and rehydration, tissue sections were
analyzed by Hematoxylin-Eosin (H-E) and Masson’s trichrome
(MTC) staining. The functionalities of acinar cells were studied by
measuring mucin production by Alcian Blue (AB) staining and
amylase production by immunohistochemistry (described below) in
SG tissues. The surface areas of mucin or amylase-containing
acinar cells were determined by densitometry. Three sections were
prepared for each gland and at least 3 fields per section were
examined by two blinded investigators using Metamorph software
(Molecular Devices Corporation, Sunnyvale, CA).
Immunofluorescence Confocal Microscopy
Apoptosis. Apoptotic cells in submandibular glands were
visualized using the Apoptag Plus Fluorescein In Situ Apoptosis
Detection kit (Millipore, Bedford, MA), which uses terminal
deoxynucleotidyl transferase dUTP nick-end labeling (TUNEL) to
detect DNA cleavage and chromatin condensation. After depar-
affinization and rehydration, slides were incubated with the
TUNEL reaction mixture containing TdT enzyme for 1 h at
37uC, and then with anti-digoxigenin fluorescein for 30 min at
room temperature. Nuclei were visualized using 49,6-diamidino-2-
phenylindole dihydrochloride (DAPI). Two blinded examiners
independently counted numbers of apoptotic cells in 3 random
fields per tissue section. At least 3 random tissue sections per gland
were mounted on each slide.
Cell proliferation. To detect proliferating cells, tissue
sections were stained with anti-proliferating cell nuclear antigen
(PCNA, Cell Signaling, Beverly, MA). After deparaffinization and
rehydration, tissue sections were treated with citrate buffer solution
(9 mL of 0.1 M citric acid and 41 mL of 0.1 M sodium citrate in
450 mL distilled water) in a 600 W microwave and then allowed to
cool to room temperature. Tissue sections were then incubated
with primary mouse PCNA antibody overnight at 4uC, washed in
PBS, blocked, and incubated with Alexa Fluor 555 conjugated
anti-mouse IgG (Cell Signaling, Beverly, MA) for 1 h at room
temperature. Two blinded independent examiners then counted
numbers of apoptotic cells in three random fields per tissue section.
At least three random tissue sections per gland were mounted on
each slide.
In vivo engraftment and
transdifferentiation. Fluorescent in situ hybridization (FISH)
analysis was performed using human-specific Alu probes. Briefly,
at least three random tissue sections per gland from ten mice were
chosen for evaluation. Salivary tissue sections were deparaffinized
and subjected to epitope retrieval in citrate buffer (pH 6.0).
Tissue section slides were then incubated with a fluorescein-
labeled Alu probe (PR-1001-01; BioGenex, San Ramon, CA),
denatured at 85uC for 10 minutes, and hybridized overnight at
37uC in moist chamber. After stringent washing, nonspecific
binding was blocked with 1% BSA for 60 min at 37uC. Human
Alu probe was detected using biotinylated anti-fluorescein
antibody (10 mg/mL, Vector Laboratories, Burlingame, CA)
followed by fluorescein (FITC) conjugated AffiniPure goat anti-
Armenian hamster IgG (10 mg/mL, Jackson ImmnoResearch
Labs, West Grove, PA).
Primary polyclonal anti-a-amylase (1:100, Cell Signaling)
antibodies were used to test the functionality of acinar cells and
the differentiation of hAdMSCs into SGCs. Tissue sections were
incubated with primary polyclonal anti-a-amylase antibodies
overnight at 4uC and then washed 3 times with PBS. Slides were
incubated at room temperature for 2 h with Alexa Fluor 555
conjugated anti-mouse IgG (Cell Signaling, Beverly, MA). Nuclei
were visualized with DAPI. All experiments included a slide with
no primary antibody as a negative control. Slides were visualized
using a confocal laser scanning microscope (Olympus FV1000,
Japan).
In vitro Differentiation
Isolation of SGCs. SGCs were obtained from adult mice. In
brief, submandibular glands were harvested from three 5-week-old
male C3H mice, mechanically minced with a fine curved scissors,
and enzymatically dissociated with 0.1% collagenase type II. After
inactivating collagenase activity with 10% FBS, cell pellets were
filtered through a 70 mm cell strainer, resuspended in medium
containing 10% FBS and 1% antibiotics, and then cultured at
37uC in a 5% CO2 atmosphere in a humidified incubator. After 5
days of culture, nonadherent cells were discarded, and adherent
cells were thoroughly washed twice with 10% PBS.
Co-culture of hAdMSCs and SGCs. To test for the
generation of amylase producing cells among hAdMSCs in vitro,
a co-culture system was used whereby isolated SGCs and
hAdMSCs were cultured for 5 days in the two chambers of a
Transwell system separated by a polycarbonate membrane
(Transwell-Clear system 6-well plate; SPL Lifesciences, Pocheon,
Korea). For co-culture experiments, hAdMSCs (26104 cells/6-
well and 36103 cells/24-well) were cultured in the lower chamber
and SGCs (26104 cell/6-well and 36103 cells/24-well) in the
upper chamber (i.e., on the polyester membrane). The culture
medium used was a low-glucose DMEM containing 1% antibiotics
and 10% FBS. The polycarbonate membrane had 0.4 mm-sized
pores, which allowed the passage of soluble factors between
hAdMSCs and SGCs, but did not allow cells to migrate from one
chamber to the other. Transwell plates containing hAdMSCs
cultured alone were used as controls.
Immunostaining and confocal
microscopy. Immunocytochemical analysis for a-amylase
(Santa Cruz, CA) was performed to evaluate the transdifferentia-
tion of co-cultured hAdMSCs after 5 days of culture. Briefly, cells
were fixed for 30 min in 4% PFA, washed three times with PBS,
incubated for 1 h at room temperature in antibody diluent reagent
solution, and incubated overnight at 4uC in a humid chamber with
anti-a-amylase antibodies. After rinsing 3 times with PBS, slides
were incubated at room temperature for 1 h with Alexa Fluor 488
Goat Anti-Mouse IgG (Molecular Probes, Invitrogen, Carlsbad,
CA), washed three times in PBS, covered with Vectashield
mounting medium containing DAPI, and analyzed under a
fluorescence microscope.
Reverse transcription polymerase chain reaction. Total
RNA was isolated from cells using TRIzol Reagent (Invitrogen)
and converted to cDNA using the PrimeScriptTM RT reagent Kit
(TaKaRa, Otsu, Japan). The PCR amplification of a-AMY was
performed using AccuPower PCR PreMix (Bioneer, Korea) at
94uC for 5 minutes, 30 amplification cycles (94uC for 30 seconds,
55uC for 30 seconds, and 72uC for 30 seconds), followed by
extension at 72uC for 10 minutes. The primers used for the PCR
were forward AATTGATCTGGGTGGTGAGC and reverse
CTTATTTGG- CGCCATCGATG.
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Statistical Analysis
Statistical analysis was conducted using the Graph Pad Prism 5
package (GraphPad Software Inc., La Jolla, CA). The Mann-
Whitney test was used to determine differences between two
groups, and the Kruskal-Wallis test with Dunn’s post hoc test to
determine differences between three groups. P values of less than
0.05 were considered statistically significant.
Results
Characteristics of hAdMSCs
The mesenchymal stem cells used in this study were highly
purified with the CD73- and CD90-positive, and CD31-, CD34-
and CD-45-negative immunophenotype. Multiple differentiation
capacity towards osteogenic, adipogenic and chondrogenic line-
ages was also confirmed in vitro (Fig. S2). These cell characteristics
are consistent with previous findings obtained using the same
culture methods. [15].
Macromorphologic and Functional Improvements after
hAdMSC Administration
Macromorphologic findings at 12 weeks after irradiation
showed that irradiation significantly reduced body weight in
irradiated untreated mice (24.361.8 g, P,0.05) as compared with
non-irradiated normal mice (27.562.8 g, Fig. S3A). Intravenously
injected hAdMSCs tended to increase body weights in the
hAdMSC-treated group (26.461.5 g) versus the irradiated group,
although this increase was not statistically significant. However,
SG weights at 12 weeks after irradiation were not significantly
different among the three study groups (P=0.255, Fig. S3B).
To determine whether hAdMSC administration improved
salivary secretory function, saliva production rates and salivary
lag times were measured at 12 weeks after irradiation. The
irradiated group showed a significantly reduced ability to produce
saliva (5.5662.91 mg/min) as compared with the normal group
(17.6464.2 mg/min, P,0.001, Fig. 1A). SFR post-stimulation was
significantly higher (11.9862.6 mg/min) in the hAdMSC group
than in the irradiated group (P,0.01). Salivary lag time was
significantly greater in the irradiated group (195.5627.42 sec,
Fig. 1B) than in the normal group (156.7630.77 sec, P,0.05).
Salivary lag time in the hAdMSC group showed a trend toward
improvement (164617.03 sec), but this was not significant.
Changes in the Micromorphologies and Functionalities of
Transplanted Submandibular Glands
Microscopic morphologic changes were visualized by hematox-
ylin-eosin (H-E) or Masson’s trichrome (MTC) staining. H-E
staining revealed at 12 weeks after irradiation, hAdMSC-treated
SGs showed more preserved structures and greater numbers of
acini than irradiated, untreated SGs (Fig. 2). hAdMSC-treated
SGs also exhibited less periductal and perivascular fibrosis than
untreated SGs.
The functionalities of acini were assessed by measuring mucin
and amylase production in SG acini (Fig. 3A). Mucin-containing
acini stained with alcian blue (AB) appeared to be more numerous
in hAdMSC-treated SGs than in irradiated SGs. These findings
were confirmed by quantifying the surface areas occupied by
mucin (P,0.01, Fig. 3B). Immunohistochemical analysis of SGs
showed that amylase production was significantly lower in
irradiated SGs than in normal SGs (P,0.001, Fig. 3C). However,
SGs in the hAdMSC-treated group showed higher levels of tissue
amylase production than SGs in the irradiated group, and this
finding was confirmed by densitometric analysis (P,0.01).
Protective Effect of hAdMSCs against Radiation-induced
Salivary Tissue Damage
Next, we explored the mechanisms responsible for these
morphological and functional improvements in hAdMSC-treated
SGs after irradiation (Fig. 4A). A TUNEL assay at 4 weeks after
irradiation revealed that few TUNEL-positive apoptotic cells were
observed in normal SGs, whereas in irradiated SGs, the number of
irradiation-induced apoptotic cells was significantly higher
(P,0.01, Fig. 4B). hAdMSC administration significantly reduced
the number of TUNEL-positive apoptotic cells as compared with
the irradiated group (P,0.05).
PCNA assays conducted at 4 weeks after transplantation showed
that proliferation indices tended to be higher for hAdMSC-treated
SGs than for untreated SGs at 4 weeks after irradiation (Fig. 4C).
Homing and the Transdifferentiation Potential of
hAdMSCs after Systemic Administration
Next, we investigated whether intravenously administered
hAdMSCs homed to irradiated SGs and transdifferentiated into
SGCs. The presence of human-specific chromosomal DNA was
analyzed by FISH using human Alu DNA. To verify the
transdifferentiation of engrafted hAdMSCs, immunofluorescence
histochemistry was performed using a-amylase (Fig. 5). At 4 weeks
Figure 1. Macromorphologic findings at 12 weeks after irradiation. (A) Saliva production (SFR, mL/min) post-stimulation in the hAdMSC
group was significantly higher than in the irradiated group. (B) The hAdMSC group tended to have shorter time to salivation (lag time). (*P,0.05,
**P,0.01, ***P,0.001).
doi:10.1371/journal.pone.0071167.g001
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Figure 2. The micromorphologic changes after irradiation were visualized by H-E and MTC stainings at 12 weeks after irradiation.
hAdMSC-treated SGs showed a well-preserved morphology and an greater number of acini than irradiated SGs. hAdMSC-treated SGs also exhibited
less periductal and perivascular fibrosis than untreated SGs. Bar = 50 mm in H-E and 100 mm in MTC staining.
doi:10.1371/journal.pone.0071167.g002
Figure 3. Functionalities of acinar cells at 12 weeks after irradiation. (A) The functions of acini after irradiation were evaluated by quantifying
the surface areas occupied by mucin and amylase in salivary gland tissues. The productions of mucin (B) and amylase (C) were lower in irradiated SGs
than in normal SGs. SGs in the hAdMSC group showed more mucin and tissue amylase production than SGs in the irradiated group. At least three
random tissue sections per gland from ten mice were chosen for evaluation. Bar = 50 mm, **P,0.01, ***P,0.001.
doi:10.1371/journal.pone.0071167.g003
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after systemic transplantation, hAdMSCs reactive to human-
specific Alu by FISH were found in SGs damaged by irradiation,
whereas no positive immunostaining was observed in control mice.
Some human Alu-positive cells also expressed a-amylase, the
acinar cell marker. These results suggest that systemically
administered hAdMSCs are able to transdifferentiate into SGCs.
In vitro Transdifferentiation of Cocultured hAdMSCs
Finally, we confirmed the in vivo finding that hAdMSCs
transdifferentiated into SGCs using an in vitro co-culture system.
The results obtained showed that a low number of co-cultured
hAdMSCs (13%–18%) stained positively for a-amylase, whereas
a-amylase staining was not observed in hAdMSCs cultured alone
(Fig. 6A). a-AMY gene expression was detected in cocultured
hAdMSCs, but was detected in control hAdMSCs (Fig. 6B). This
observation suggests that hAdMSCs possess the potential to
transdifferentiate into SGCs producing amylase in vitro.
Discussion
This study was undertaken to determine whether the systemic
administration of human adipose-derived mesenchymal stem cells
(hAdMSCs) ameliorates radiation-induced SG damage. The
findings obtained showed that intravenously infused hAdMSCs
engraft into the SGs of mice subjected to local irradiation. In
addition, it was found that hAdMSCs transplanted into irradiated
SGs afford protection against radiation-induced cell damage,
promote regeneration of SGCs, and some of localized cells have
the potential to transdifferentiate into SGCs of the endodermal
lineage.
The specific homing of systemically infused mesenchymal stem
cells (MSCs) to irradiation-induced lesions was demonstrated in
2006 by Francois et al., who suggested the migration of MSCs to
injured tissues is initiated by a signal released from inflamed tissue
shortly after injury, and that level of MSC engraftment is related to
the timing, dose, and distribution of irradiation. [17] Furthermore,
it has been reported that human MSCs show persistent
engraftment when transplanted into an immune-incompetent
Figure 4. Immunofluorescent TUNEL and PCNA assays at 4 weeks after irradiation. (A and B) TUNEL assays revealed few TUNEL-positive
apoptotic cells among normal SGs, but significant numbers in irradiated SGs. hAdMSC administration significantly reduced TUNEL-positive apoptotic
cell numbers in the hAdMSC group as compared with the irradiated group. (A and C) PCNA assays conducted at 4 weeks after transplantation
showed that proliferation indices tended to be higher for hAdMSC-treated SGs than for untreated SGs. The ratios of TUNEL- and PCNA-positive cells
versus all DAPI-positive cells were calculated in random tissue sections. At least three random tissue sections per gland from ten mice were chosen
for evaluation. Bar = 50 mm, *P,0.05, **P,0.01.
doi:10.1371/journal.pone.0071167.g004
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host. [18] The homing to injured SGs by administered cells can be
also promoted using an enhancing agent. [11].
In this study, we administered hAdMSCs systemically within 6
hours of 15 Gy of neck irradiation and repeated the infusion once
a week for 3 consecutive weeks. Infused hAdMSCs were found to
have localized 4 weeks after initial infusion. However, immuno-
fluorescent staining revealed the number of hAdMSCs that
successfully engrafted and differentiated to SGCs was low.
Although we did not perform quantitative analysis, MSC
engraftment in damaged SGs was also observed by Sumita et al.,
who detected 9% donor-derived salivary epithelial cells in BSC-
treated SGs after an intravenous infusion immediately after
irradiation. [19] Additional investigations on the optimal number
of delivered cells and on the optimal timing required for clinically
useful damaged tissue restoration are required.
AdMSCs have been used for cellular therapy via local or
systemic administration for a variety of indications. In particular,
the systemic infusion of AdMSCs has been shown to be beneficial
in the contexts of graft-versus-host-defense (GVHD), [20] rheu-
matic disease, [21] and thyroiditis. [22] AdMSCs appear to be
capable of migrating to an injured site through the bloodstream
and to have a positive effect on the repair or restoration of
damaged tissues via several mechanisms, which include paracrine
effects, vasculogenesis, cell fusion and/or cell transdifferentiation.
Recently, Kojima et al. reported that the direct administration
of AdMSCs has the potential to restore SG function by restoring
blood flow within submandibular gland tissues. [22] However,
they did not observe significant transdifferentiation into salivary
gland cells. In our experimental setup, the systemic administration
of hAdMSCs after irradiation improved morphology and func-
tional regeneration, not only in terms of protection against
radiation-induced cell death but also because of the replacement of
SGCs by transdifferentiation. Moreover, our coculture experiment
revealed that cocultured hAdMSCs expressed a-amylase in vitro,
and furthermore, a-AMY gene expression was also confirmed by
PCR. These findings are in accord with earlier work published by
Maria and Tran, [23] who found that a proportion of MSCs
temporarily adopt a salivary epithelial phenotype by mesenchy-
mal-to-epithelial transition induced by cross-talk between cells and
the microenvironment. To the best of our knowledge, our results
Figure 5. Homing of intravenously administered hAdMSCs to
irradiated SGs and their transdifferentiation into SGCs at 4
weeks after systemic administration. FISH revealed cells reactive to
human specific Alu DNA (green, arrow) in irradiated SGs. A few Alu-
positive cells were also positive for the acinar cell marker, a-amylase
(red). At least three random tissue sections per gland from ten mice
were chosen for evaluation. DAPI (blue), Bar = 20 mm.
doi:10.1371/journal.pone.0071167.g005
Figure 6. Immunofluorescent microscope image showing the transdifferentiation of hAdMSCs into amylase-producing cells after
co-culture with SGCs. (A) Approximately 13%–18% of hAdMSCs co-cultured in the upper chamber of a Transwell co-culture system for 5 days
stained positively for a-amylase (red). AdMSCs cultured alone only showed the nuclear expression of hAdMSCs (blue). Bar = 50 mm (B) Reverse
transcription-polymerase chain reaction analysis confirmed a-AMY gene expression from the cocultured hAdMSCs, but no band was seen in the
hAdMSC control. Human SGCs were used as a positive control.
doi:10.1371/journal.pone.0071167.g006
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provide first evidence of the functional restoration of salivary
glands by the systemic migration of hAdMSCs into irradiation-
damaged tissues and of the contribution made by hAdMSCs to
tissue repair by differentiation. These results also support the
notion that MSCs derived from embryonic mesenchyme have the
potential to differentiate into different tissue lineages, such as,
hepatocytes and pancreatic cells. [24,25].
The tissue regeneration of SGs has also been suggested to be
related to AdMSC-induced paracrine stimulation. Recently, the
release of paracrine mediators, such as, growth factors and
chemokines, was reported to provide acute radioprotection. [26]
In the present study, the reduction of apoptosis observed in the
hAdMSC-treated SGs was probably related to the anti-apoptotic
effects of stem cells due to the local paracrine secretion of
hAdMSC-derived bioactive components. These findings are
consistent with a previous report, in which it was found that
BSC-transplanted SGs showed increased tissue regenerating
activities, such as, blood vessel formation and cell proliferation,
and a decrease in apoptotic activity. [19] In the present study,
infused hAdMSCs survived at lesions for 4 weeks, but only a few
transdifferentiated into salivary acinar cells, which produce
amylase in vivo. This suggests that a paracrine effect, rather than
transdifferentiation, is responsible for the amelioration of radiation
damage by promoting the survival of endogenous progenitor cells
or neovascularization. Further investigations are required to
elucidate the process responsible for hAdMSC-mediated SG
regeneration.
The efforts of researchers to establish the safety of MSC infusion
have led to the use of MSCs delivered via systemic infusion for the
treatment of various diseases. [27] We used human-derived
AdMSCs cultured and expanded under GMP conditions, because
this is for a prerequisite of future clinical trials. In fact, hAdMSCs
have already been determined to be non-toxic and non-
tumorigenic in animal models and in clinical trials. [15] In the
present study, after systemic transplantation, hAdMSCs success-
fully engrafted in the xenogeneic SGs without signs of toxicity, and
preserved their ability to undergo differentiation into mature tissue
according to the recipient environment.
Xenogenic models are useful, but results are inevitably
controversial. In the case of MSCs, although the xenogenicity
does not interrupt the differentiation of MSCs, it can induce
transplantation rejection. [17] Nevertheless, the survival of human
MSCs after xenogeneic transplantation into immune competent
mice without immunosuppression adjustment is presumed to be
related to the immune-privileged properties of stem cells. [14] The
immune evasion strategies of human MSCs have not been
clarified, but several factors have been identified, including
hypoimmunogenicity, the modulation of immune cell function,
and the creation of a suppressive microenvironment. [28].
Several issues will need to be addressed in order to enable the
clinical use of stem cell transplantation for the functional
restoration of irradiation-inflicted SGs. First, a suitable preclinical
animal model for transplantation that allows the engraftment of
xenogeneic human stem cells should be established. Second,
appropriate routes for transplantation, including intravenous
injection, local transplantation by direct injection, and retroductal
administration via an excretory duct, should be determined.
Third, cultured cells should be harvested and isolated without
contamination and expanded in a laboratory with adequate
quality control. We believe our descripted model is useful for
preclinical research purposes, and that it could be used to improve
protection against radiation-induce damage and to restore salivary
gland function after irradiation.
In conclusion, this study shows that systemically administered
hAdMSCs are capable of migrating to an injured site through the
bloodstream and becoming engrafted into xenogeneic SG tissues.
Furthermore, our findings suggest hAdMSCs have the potential to
transdifferentiate into SGCs and that they offer protection against
radiation-induced cell damage. We believe that hAdMSCs should
be viewed as candidates for cell-based therapy for the restoration
of radiation-induced SG hypofunction.
Supporting Information
Figure S1 Schematic representation of the experimental
setup. The external irradiation dose of 15 Gy was administered
to neck fields of C3H mice. Mice received 16106 hAdMSCs
through the tail vein immediately after irradiation, and this
infusion was repeated once a week for 3 consecutive weeks.
(TIF)
Figure S2 Characterization of culture expanded human
adipose mesenchymal stem cells. (A) Flow cytometry
analyses demonstrated that hASCs expressed CD105, HLA-
ABC, CD44, CD29, CD73, and CD90, but were negative for
HLA-DR, CD45, CD34, and CD31. (B) In vitro differentiation
assays confirmed the multipotency of hASCs. Cells were positive
for Alizarin red (upper-left), Oil Red-O (upper-middle), or
Toluidine blue (upper-right) staining after osteogenic, adipogenic,
or chondrogenic induction. Undifferentiated cells were not stained
by Alizarin red or Oil Red-O staining (bottom). Scale
bars = 100 mm.
(TIF)
Figure S3 Macromorphologic findings at 12 weeks after
irradiation. (A) Locally irradiated mice showed significant
decrease in body weights (BWs) measured at 12 weeks after
irradiation. (B) Salivary gland weights (SGWs) normalized to BWs
was not significantly different between the three study groups.
(TIF)
Acknowledgments
This paper was presented at the 4th World Congress of the International
Academy of Oral Oncology on May 14–17, 2013, in Greece.
Author Contributions
Conceived and designed the experiments: J-YL. Performed the experi-
ments: J-YL JCR YHJ H-YA WCK. Analyzed the data: J-YL JCR J-SC.
Contributed reagents/materials/analysis tools: JCR YHJ ISS. Wrote the
paper: J-YL JCR YHJ Y-MK.
References
1. Jensen SB, Pedersen AM, Vissink A, Andersen E, Brown CG, et al. (2010) A
systematic review of salivary gland hypofunction and xerostomia induced by
cancer therapies: prevalence, severity and impact on quality of life. Support Care
Cancer 18: 1039–1060.
2. Vissink A, Jansma J, Spijkervet FK, Burlage FR, Coppes RP (2003) Oral
sequelae of head and neck radiotherapy. Crit Rev Oral Biol Med 14: 199–212.
3. Chambers MS, Garden AS, Kies MS, Martin JW (2004) Radiation-induced
xerostomia in patients with head and neck cancer: pathogenesis, impact on
quality of life, and management. Head Neck 26: 796–807.
4. Sugito T, Kagami H, Hata K, Nishiguchi H, Ueda M (2004) Transplantation of
cultured salivary gland cells into an atrophic salivary gland. Cell Transplant 13:
691–699.
5. Aframian DJ, Palmon A (2008) Current status of the development of an artificial
salivary gland. Tissue Eng Part B Rev 14: 187–198.
Regeneration of Radiation-Induced Salivary Damage
PLOS ONE | www.plosone.org 8 August 2013 | Volume 8 | Issue 8 | e71167
6. Coppes RP, Stokman MA (2011) Stem cells and the repair of radiation-induced
salivary gland damage. Oral Dis 17: 143–153.
7. Lombaert IM, Brunsting JF, Wierenga PK, Faber H, Stokman MA, et al. (2008)
Rescue of salivary gland function after stem cell transplantation in irradiated
glands. PLoS One 3: e2063.
8. Baum BJ, Zheng C, Alevizos I, Cotrim AP, Liu S, et al. (2010) Development of a
gene transfer-based treatment for radiation-induced salivary hypofunction. Oral
Oncol 46: 4–8.
9. Tran SD, Sumita Y, Khalili S (2011) Bone marrow-derived cells: A potential
approach for the treatment of xerostomia. Int J Biochem Cell Biol 43: 5–9.
10. Lombaert IM, Wierenga PK, Kok T, Kampinga HH, deHaan G, et al. (2006)
Mobilization of bone marrow stem cells by granulocyte colony-stimulating factor
ameliorates radiation-induced damage to salivary glands. Clin Cancer Res 12:
1804–1812.
11. Lombaert IM, Brunsting JF, Wierenga PK, Kampinga HH, de Haan G, et al.
(2008) Cytokine treatment improves parenchymal and vascular damage of
salivary glands after irradiation. Clin Cancer Res 14: 7741–7750.
12. Lim JY, Yi T, Choi JS, Jang YH, Lee S, et al. (2013) Intraglandular
transplantation of bone marrow-derived clonal mesenchymal stem cells for
amelioration of post-irradiation salivary gland damage. Oral Oncol 49: 136–
143.
13. Sen A, Lea-Currie YR, Sujkowska D, Franklin DM, Wilkison WO, et al. (2001)
Adipogenic potential of human adipose derived stromal cells from multiple
donors is heterogeneous. J Cell Biochem 81: 312–319.
14. Saito T, Kuang JQ, Bittira B, Al-Khaldi A, Chiu RC (2002) Xenotransplant
cardiac chimera: immune tolerance of adult stem cells. Ann Thorac Surg 74:
19–24; discussion 24.
15. Ra JC, Shin IS, Kim SH, Kang SK, Kang BC, et al. (2011) Safety of intravenous
infusion of human adipose tissue-derived mesenchymal stem cells in animals and
humans. Stem Cells Dev 20: 1297–1308.
16. Konings AW, Coppes RP, Vissink A (2005) On the mechanism of salivary gland
radiosensitivity. Int J Radiat Oncol Biol Phys 62: 1187–1194.
17. Francois S, Bensidhoum M, Mouiseddine M, Mazurier C, Allenet B, et al. (2006)
Local irradiation not only induces homing of human mesenchymal stem cells at
exposed sites but promotes their widespread engraftment to multiple organs: a
study of their quantitative distribution after irradiation damage. Stem Cells 24:
1020–1029.
18. Grinnemo KH, Mansson A, Dellgren G, Klingberg D, Wardell E, et al. (2004)
Xenoreactivity and engraftment of human mesenchymal stem cells transplanted
into infarcted rat myocardium. J Thorac Cardiovasc Surg 127: 1293–1300.
19. Sumita Y, Liu Y, Khalili S, Maria OM, Xia D, et al. (2011) Bone marrow-
derived cells rescue salivary gland function in mice with head and neck
irradiation. Int J Biochem Cell Biol 43: 80–87.
20. Yanez R, Lamana ML, Garcia-Castro J, Colmenero I, Ramirez M, et al. (2006)
Adipose tissue-derived mesenchymal stem cells have in vivo immunosuppressive
properties applicable for the control of the graft-versus-host disease. Stem Cells
24: 2582–2591.
21. Zhou B, Yuan J, Zhou Y, Ghawji M, Jr., Deng YP, et al. (2011) Administering
human adipose-derived mesenchymal stem cells to prevent and treat
experimental arthritis. Clin Immunol 141: 328–337.
22. Choi EW, Shin IS, Lee HW, Park SY, Park JH, et al. (2011) Transplantation of
CTLA4Ig gene-transduced adipose tissue-derived mesenchymal stem cells
reduces inflammatory immune response and improves Th1/Th2 balance in
experimental autoimmune thyroiditis. J Gene Med 13: 3–16.
23. Maria OM, Tran SD (2011) Human mesenchymal stem cells cultured with
salivary gland biopsies adopt an epithelial phenotype. Stem Cells Dev 20: 959–
967.
24. Seo MJ, Suh SY, Bae YC, Jung JS (2005) Differentiation of human adipose
stromal cells into hepatic lineage in vitro and in vivo. Biochem Biophys Res
Commun 328: 258–264.
25. Kang HM, Kim J, Park S, Kim H, Kim KS, et al. (2009) Insulin-secreting cells
from human eyelid-derived stem cells alleviate type I diabetes in immunocom-
petent mice. Stem Cells 27: 1999–2008.
26. Gao Z, Zhang Q, Han Y, Cheng X, Lu Y, et al. (2012) Mesenchymal stromal
cell-conditioned medium prevents radiation-induced small intestine injury in
mice. Cytotherapy 14: 267–273.
27. Kang SK, Shin IS, Ko MS, Jo JY, Ra JC (2012) Journey of mesenchymal stem
cells for homing: strategies to enhance efficacy and safety of stem cell therapy.
Stem Cells Int 2012: 342968.
28. Ryan JM, Barry FP, Murphy JM, Mahon BP (2005) Mesenchymal stem cells
avoid allogeneic rejection. J Inflamm (Lond) 2: 8.
Regeneration of Radiation-Induced Salivary Damage
PLOS ONE | www.plosone.org 9 August 2013 | Volume 8 | Issue 8 | e71167
